Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal formulation for treating scar

A drug and scar technology, applied in the field of human medicine, can solve problems such as difficult recovery, inability to use, skin damage, etc., and achieve the effect of easy use

Inactive Publication Date: 2007-05-23
冯时 +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Some also cause skin damage, or local pain, and the curative effect is unsatisfactory. Simple local injection of triamcinolone or ointment or ointment containing triamcinolone can only control the development of the disease and relieve symptoms, and it is not easy to recover
90 The effective rate of sticking treatment is less than 40%. Deep X-ray radiotherapy after surgery or ionization has high effective rate, but it brings different degrees of damage to the human body
At the same time, it cannot be used near the reproductive system of special parts such as the chest line, children and nulliparous patients.
Otherwise, there will be serious consequences

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] , make A, B, C, D, E, F, G, H and other different dosage forms respectively:

[0018] A preparation:

[0019] Hyaluronidase 2 parts,

[0020] Triamcinolone 40 parts,

[0021] Azothracene 333 parts,

[0022] 200 parts hydrolyzed gelatin

[0023] 2000 parts of normal saline.

[0024] Preparation B:

[0025] Hyaluronidase 2 parts,

[0026] Triamcinolone 40 parts,

[0027] Azothracene 333 parts,

[0028] Glyceryl monostearate 2000 parts.

[0029] Preparation C:

[0030] Hyaluronidase 2 parts,

[0031] Triamcinolone 40 parts,

[0032] Azothracene 333 parts,

[0033] Polyvinyl formal 2000 parts.

[0034] D preparation:

[0035] Hyaluronidase 2 parts,

[0036] Triamcinolone 40 parts,

[0037] Azothracene 333 parts,

[0038] Polyisobutylene (MML.100) 3000 parts.

[0039] Preparation E:

[0040] Hyaluronidase 2 parts,

[0041] Triamcinolone 40 par...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug made from alidase, glucocorticoids, triamcinoloni acetonidi acetas, and aromatic compound. The invention can affect protein metabolism, interfere fiber increment, etc. And it comprises 2 deals alidase, 40 deals glucocorticoids, 333 deals aromatic compound, and 2000-3000 deals agent xo; the agent xo can be 200 deals of hydrocolloid, 2000 deals of glycerol monostearate, 2000 deals of plyvinyl formal, 3000 deals polyisobutene (MML.100), 2000 deals glycerin, 2000 deals hydroxyethyl methacrylate (P-HEMA), 2000 deals propanediol, 2000 deals soybean phosphatides, or 2000 deals normal saline.

Description

technical field [0001] The invention belongs to the field of human medicine, and particularly relates to a pharmaceutical preparation formed by combining a biological product hyaluronidase and triamcinolone, carrying a penetrant azoanthrene, and an auxiliary agent. It has the mechanism of affecting sugar and protein metabolism, strengthening gluconeogenesis, promoting protein decomposition, enhancing metabolism, and interfering with fibrous proliferation. Locally raised, hard, flushed, and itchy keloids formed by excessive deposition of metabolites are pharmaceutical preparations that have the therapeutic effects of flattening, softening, reddening, and relieving pain and itching. Background technique [0002] The mechanism of scar formation is mainly formed by excessive fibrin proliferation and excessive deposition of collagen fibers. Due to the imbalance of collagen synthesis and degradation, the appearance of abnormal mucopolysaccharides, and the proliferation of muscle ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/43A61K31/58A61K31/55A61P17/02
Inventor 冯时张放
Owner 冯时
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com